Neo Ivy Capital Management - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$375
-99.6%
15,099
+189.9%
0.20%
+70.7%
Q3 2021$101,000
-66.2%
5,209
-32.4%
0.12%
-61.6%
Q2 2021$299,000
+199.0%
7,704
+272.4%
0.30%
+174.5%
Q1 2021$100,000
-22.5%
2,069
-16.8%
0.11%
-23.6%
Q4 2020$129,000
-7.2%
2,487
-52.2%
0.14%
+2.1%
Q3 2020$139,000
+37.6%
5,208
-0.0%
0.14%
+271.1%
Q2 2020$101,0005,2090.04%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders